Global Infection Control in Cancer Therapy Market Size, Status and Forecast 2019-2025

Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Infection Control in Cancer Therapy Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 Radiation Therapy
  • 1.4.3 Immunotherapy
  • 1.4.4 Traditional Surgery
  • 1.4.5 Stem Cell Transplant Therapy
  • 1.4.6 Chemotherapy
  • 1.4.7 Targeted Therapy
  • 1.4.8 Photodynamic Therapy
  • 1.4.9 Other
• 1.5 Market by Application
  • 1.5.1 Global Infection Control in Cancer Therapy Market Share by Application (2014-2025)
  • 1.5.2 Hospital
  • 1.5.3 Pharmaceutical Companies
  • 1.5.4 Medical device companies
  • 1.5.5 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Infection Control in Cancer Therapy Market Size
• 2.2 Infection Control in Cancer Therapy Growth Trends by Regions
  • 2.2.1 Infection Control in Cancer Therapy Market Size by Regions (2014-2025)
  • 2.2.2 Infection Control in Cancer Therapy Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Opportunities

3 Market Share by Key Players

• 3.1 Infection Control in Cancer Therapy Market Size by Manufacturers
  • 3.1.1 Global Infection Control in Cancer Therapy Revenue by Manufacturers (2014-2019)
  • 3.1.2 Global Infection Control in Cancer Therapy Revenue Market Share by Manufacturers (2014-2019)
  • 3.1.3 Global Infection Control in Cancer Therapy Market Concentration Ratio (CR5 and HHI)
• 3.2 Infection Control in Cancer Therapy Key Players Head office and Area Served
• 3.3 Key Players Infection Control in Cancer Therapy Product/Solution/Service
• 3.4 Date of Enter into Infection Control in Cancer Therapy Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Infection Control in Cancer Therapy Market Size by Type (2014-2019)
• 4.2 Global Infection Control in Cancer Therapy Market Size by Application (2014-2019)

5 United States

• 5.1 United States Infection Control in Cancer Therapy Market Size (2014-2019)
• 5.2 Infection Control in Cancer Therapy Key Players in United States
• 5.3 United States Infection Control in Cancer Therapy Market Size by Type
• 5.4 United States Infection Control in Cancer Therapy Market Size by Application

6 Europe

• 6.1 Europe Infection Control in Cancer Therapy Market Size (2014-2019)
• 6.2 Infection Control in Cancer Therapy Key Players in Europe
• 6.3 Europe Infection Control in Cancer Therapy Market Size by Type
• 6.4 Europe Infection Control in Cancer Therapy Market Size by Application

7 China

• 7.1 China Infection Control in Cancer Therapy Market Size (2014-2019)
• 7.2 Infection Control in Cancer Therapy Key Players in China
• 7.3 China Infection Control in Cancer Therapy Market Size by Type
• 7.4 China Infection Control in Cancer Therapy Market Size by Application

8 Japan

• 8.1 Japan Infection Control in Cancer Therapy Market Size (2014-2019)
• 8.2 Infection Control in Cancer Therapy Key Players in Japan
• 8.3 Japan Infection Control in Cancer Therapy Market Size by Type
• 8.4 Japan Infection Control in Cancer Therapy Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Infection Control in Cancer Therapy Market Size (2014-2019)
• 9.2 Infection Control in Cancer Therapy Key Players in Southeast Asia
• 9.3 Southeast Asia Infection Control in Cancer Therapy Market Size by Type
• 9.4 Southeast Asia Infection Control in Cancer Therapy Market Size by Application

10 India

• 10.1 India Infection Control in Cancer Therapy Market Size (2014-2019)
• 10.2 Infection Control in Cancer Therapy Key Players in India
• 10.3 India Infection Control in Cancer Therapy Market Size by Type
• 10.4 India Infection Control in Cancer Therapy Market Size by Application

11 Central & South America

• 11.1 Central & South America Infection Control in Cancer Therapy Market Size (2014-2019)
• 11.2 Infection Control in Cancer Therapy Key Players in Central & South America
• 11.3 Central & South America Infection Control in Cancer Therapy Market Size by Type
• 11.4 Central & South America Infection Control in Cancer Therapy Market Size by Application

12 International Players Profiles

• 12.1 Kimberly Clark Corporation
  • 12.1.1 Kimberly Clark Corporation Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Infection Control in Cancer Therapy Introduction
  • 12.1.4 Kimberly Clark Corporation Revenue in Infection Control in Cancer Therapy Business (2014-2019)
  • 12.1.5 Kimberly Clark Corporation Recent Development
• 12.2 3M Healthcare Company
  • 12.2.1 3M Healthcare Company Company Details
  • 12.2.2 Company Description and Business Overview
  • 12.2.3 Infection Control in Cancer Therapy Introduction
  • 12.2.4 3M Healthcare Company Revenue in Infection Control in Cancer Therapy Business (2014-2019)
  • 12.2.5 3M Healthcare Company Recent Development
• 12.3 Honeywell International, Inc.
  • 12.3.1 Honeywell International, Inc. Company Details
  • 12.3.2 Company Description and Business Overview
  • 12.3.3 Infection Control in Cancer Therapy Introduction
  • 12.3.4 Honeywell International, Inc. Revenue in Infection Control in Cancer Therapy Business (2014-2019)
  • 12.3.5 Honeywell International, Inc. Recent Development
• 12.4 Getinge Group AB
  • 12.4.1 Getinge Group AB Company Details
  • 12.4.2 Company Description and Business Overview
  • 12.4.3 Infection Control in Cancer Therapy Introduction
  • 12.4.4 Getinge Group AB Revenue in Infection Control in Cancer Therapy Business (2014-2019)
  • 12.4.5 Getinge Group AB Recent Development
• 12.5 Sterigenics International
  • 12.5.1 Sterigenics International Company Details
  • 12.5.2 Company Description and Business Overview
  • 12.5.3 Infection Control in Cancer Therapy Introduction
  • 12.5.4 Sterigenics International Revenue in Infection Control in Cancer Therapy Business (2014-2019)
  • 12.5.5 Sterigenics International Recent Development
• 12.6 Sakura Global Holding Company
  • 12.6.1 Sakura Global Holding Company Company Details
  • 12.6.2 Company Description and Business Overview
  • 12.6.3 Infection Control in Cancer Therapy Introduction
  • 12.6.4 Sakura Global Holding Company Revenue in Infection Control in Cancer Therapy Business (2014-2019)
  • 12.6.5 Sakura Global Holding Company Recent Development
• 12.7 Arizant Healthcare Inc.
  • 12.7.1 Arizant Healthcare Inc. Company Details
  • 12.7.2 Company Description and Business Overview
  • 12.7.3 Infection Control in Cancer Therapy Introduction
  • 12.7.4 Arizant Healthcare Inc. Revenue in Infection Control in Cancer Therapy Business (2014-2019)
  • 12.7.5 Arizant Healthcare Inc. Recent Development
• 12.8 Nordion
  • 12.8.1 Nordion Company Details
  • 12.8.2 Company Description and Business Overview
  • 12.8.3 Infection Control in Cancer Therapy Introduction
  • 12.8.4 Nordion Revenue in Infection Control in Cancer Therapy Business (2014-2019)
  • 12.8.5 Nordion Recent Development
• 12.9 Cisa S.P.A.
  • 12.9.1 Cisa S.P.A. Company Details
  • 12.9.2 Company Description and Business Overview
  • 12.9.3 Infection Control in Cancer Therapy Introduction
  • 12.9.4 Cisa S.P.A. Revenue in Infection Control in Cancer Therapy Business (2014-2019)
  • 12.9.5 Cisa S.P.A. Recent Development
• 12.10 Steris Corporation
  • 12.10.1 Steris Corporation Company Details
  • 12.10.2 Company Description and Business Overview
  • 12.10.3 Infection Control in Cancer Therapy Introduction
  • 12.10.4 Steris Corporation Revenue in Infection Control in Cancer Therapy Business (2014-2019)
  • 12.10.5 Steris Corporation Recent Development
• 12.11 Nordion, Inc.
• 12.12 Ahlstrom Filtration LLC
• 12.13 Membrana GmbH
• 12.14 Synergy Health, Plc
• 12.15 Advanced Sterilization Products Services, Inc

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Regions
• 13.2 United States
• 13.3 Europe
• 13.4 China
• 13.5 Japan
• 13.6 Southeast Asia
• 13.7 India
• 13.8 Central & South America
• 13.9 Market Size Forecast by Product (2019-2025)
• 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 12.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer